Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gregory

Showing results (1281-1290 of 1,329) with videos related to

Pageof 133
Sort By:
Plos One|August 29, 2018
ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenograftsAlice L Yuan, Christian B Ricks, Alexandra K Bohm, et al.
Frontiers in Cellular and Infection Microbiology|April 24, 2020
Microbiotyping the Sinonasal MicrobiomeAhmed Bassiouni, Sathish Paramasivan, Arron Shiffer, et al.
Virulence|May 19, 2022
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19David J Gregory, Augustin Vannier, Akiro H Duey, et al.
The New England Journal of Medicine|March 16, 2017
Short-Course Radiation plus Temozolomide in Elderly Patients with GlioblastomaJames R Perry, Normand Laperriere, Christopher J O'Callaghan, et al.
Microbiome|November 28, 2018
Next steps in studying the human microbiome and health in prospective studies, Bethesda, MD, May 16-17, 2017Rashmi Sinha, Habibul Ahsan, Martin Blaser, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2019
Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environmentsYaoqing Shen, Cameron J Grisdale, Sumaiya A Islam, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 23, 2013
N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancementK J Gregory, E J Herman, A J Ramsey, et al.
Arxiv|June 19, 2023
Evaluation of software impact designed for biomedical research: Are we measuring what's meaningful?Awan Afiaz, Andrey A Ivanov, John Chamberlin, et al.
The Journal of Infectious Diseases|December 10, 2021
Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 VaccinesVivek Naranbhai, Wilfredo F Garcia-Beltran, Christina C Chang, et al.
Journal of Medicinal Chemistry|January 10, 2003
Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogensMichael R Barbachyn, Gary J Cleek, Lester A Dolak, et al.
Pageof 133

Showing results (1281-1290 of 1,329) with videos related to

Sort By:
Pageof 133
Plos One|August 29, 2018
ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenograftsAlice L Yuan, Christian B Ricks, Alexandra K Bohm, et al.
Frontiers in Cellular and Infection Microbiology|April 24, 2020
Microbiotyping the Sinonasal MicrobiomeAhmed Bassiouni, Sathish Paramasivan, Arron Shiffer, et al.
Virulence|May 19, 2022
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19David J Gregory, Augustin Vannier, Akiro H Duey, et al.
The New England Journal of Medicine|March 16, 2017
Short-Course Radiation plus Temozolomide in Elderly Patients with GlioblastomaJames R Perry, Normand Laperriere, Christopher J O'Callaghan, et al.
Microbiome|November 28, 2018
Next steps in studying the human microbiome and health in prospective studies, Bethesda, MD, May 16-17, 2017Rashmi Sinha, Habibul Ahsan, Martin Blaser, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2019
Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environmentsYaoqing Shen, Cameron J Grisdale, Sumaiya A Islam, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 23, 2013
N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancementK J Gregory, E J Herman, A J Ramsey, et al.
Arxiv|June 19, 2023
Evaluation of software impact designed for biomedical research: Are we measuring what's meaningful?Awan Afiaz, Andrey A Ivanov, John Chamberlin, et al.
The Journal of Infectious Diseases|December 10, 2021
Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 VaccinesVivek Naranbhai, Wilfredo F Garcia-Beltran, Christina C Chang, et al.
Journal of Medicinal Chemistry|January 10, 2003
Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogensMichael R Barbachyn, Gary J Cleek, Lester A Dolak, et al.
Pageof 133